Melanoma Patients Immunized With Natural DenDritic Cells

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The aim of this study is to determine whether adjuvant treatment with nDC vaccination, after complete radical lymph node dissection or sentinel node procedure in stage IIIB and IIIC melanoma patients, improves recurrence-free survival (RFS) as compared to treatment with matching placebo.
Epistemonikos ID: 9e2a1095c77f5cf40e5f92e6a71ea10e96d79844
First added on: May 20, 2024